Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,997,000 | 11,631,000 | 17,940,000 | 7,588,000 | 8,229,000 |
| Marketable Securities | 1,411,000 | 12,721,000 | 12,149,000 | 17,922,000 | 3,666,000 |
| Receivables | 4,892,000 | 3,582,000 | 3,327,000 | 3,851,000 | 4,514,000 |
| Inventories | 1,683,000 | 922,000 | 814,000 | 801,000 | 1,587,000 |
| TOTAL | $15,996,000 | $30,296,000 | $35,836,000 | $31,823,000 | $19,588,000 |
| Non-Current Assets | |||||
| PPE Net | 4,967,000 | 4,502,000 | 4,006,000 | 3,295,000 | 2,865,000 |
| Investments And Advances | 502,000 | 1,488,000 | 1,423,000 | 11,184,000 | 20,485,000 |
| Intangibles | 41,234,000 | 17,903,000 | 19,855,000 | 21,259,000 | 10,143,000 |
| Other Non-Current Assets | 5,708,000 | 7,438,000 | 2,555,000 | 2,722,000 | 3,896,000 |
| TOTAL | $52,411,000 | $31,331,000 | $27,839,000 | $38,460,000 | $37,389,000 |
| Total Assets | $68,407,000 | $61,627,000 | $63,675,000 | $70,283,000 | $56,977,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,757,000 | 2,499,000 | 2,748,000 | 2,747,000 | N/A |
| Accounts payable and accrued liabilities | 844,000 | 713,000 | 790,000 | 814,000 | 1,206,000 |
| Accrued Expenses | 3,460,000 | 3,473,000 | 3,928,000 | 4,704,000 | 5,021,000 |
| TOTAL | $11,397,000 | $9,759,000 | $10,605,000 | $11,635,000 | $9,218,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,859,000 | 23,103,000 | 25,614,000 | 31,353,000 | 26,643,000 |
| Other Non-Current Liabilities | 5,050,000 | 6,137,000 | 5,917,000 | 6,778,000 | 1,766,000 |
| TOTAL | $38,789,000 | $29,218,000 | $31,536,000 | $38,147,000 | $28,396,000 |
| Total Liabilities | $50,186,000 | $38,977,000 | $42,141,000 | $49,782,000 | $37,614,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,256,593 | 1,263,637 | 1,275,511 | 1,309,968 | 1,307,067 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 14,381,000 | 19,388,000 | 19,024,000 | 19,012,000 | 18,154,000 |
| Other shareholders' equity | -41,000 | 210,000 | 227,000 | 224,000 | 754,000 |
| TOTAL | $18,221,000 | $22,650,000 | $21,534,000 | $20,501,000 | $19,363,000 |
| Total Liabilities And Equity | $68,407,000 | $61,627,000 | $63,675,000 | $70,283,000 | $56,977,000 |